| 1 | [SID11112959] | Active | Potency | 0.0079 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6 [AID891, Type: confirmatory] | cytochrome P450 2D6 isoform 1 [Homo sapiens] [gi:40805836] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Active | | Potency | 0.0079 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6 | | AID | 891 | | BioAssay type | confirmatory | | Target | cytochrome P450 2D6 isoform 1 [Homo sapiens] [gi:40805836] | | PubMed | | | Data Table |  |
|
| 2 | [SID11112959] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_2, Type: other] | cytochrome P450, family 2, subfamily D, polypeptide 6 isoform 2 [Homo sapiens] [gi:68509921] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily D, polypeptide 6 isoform 2 [Homo sapiens] [gi:68509921] | | PubMed | | | Data Table |  |
|
| 3 | [SID11112959] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_2, Type: other] | cytochrome P450, family 2, subfamily D, polypeptide 6 isoform 2 [Homo sapiens] [gi:68509921] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily D, polypeptide 6 isoform 2 [Homo sapiens] [gi:68509921] | | PubMed | | | Data Table |  |
|
| 4 | [SID26757851] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID26757851] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 6 | [SID11112959] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 7 | [SID11112959] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 8 | [SID56463089] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 9 | [SID56463089] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 10 | [SID104171335] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 104171335 | | CID | 19518 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 11 | [SID11112959] | Inactive | Potency | 1.4125 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | Potency | 1.4125 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 12 | [SID11112959] | Inactive | Potency | 1.4125 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | Potency | 1.4125 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 13 | [SID56463089] | Inactive | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 14 | [SID11112959] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 15 | [SID11112959] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 16 | [SID11112959] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 17 | [SID11112959] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 18 | [SID56463089] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 19 | [SID56463089] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 20 | [SID104171335] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 104171335 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 21 | [SID104171335] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 104171335 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 22 | [SID56463089] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 23 | [SID56463089] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 24 | [SID56463089] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 25 | [SID104171335] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 104171335 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 26 | [SID56463089] | Inactive | Potency | | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 27 | [SID11112959] | Inactive | | | GR-GFP Redistribution [AID450, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | BioAssay | GR-GFP Redistribution | | AID | 450 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 28 | [SID11112959] | Inactive | | | GR-GFP Redistribution [AID450, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | BioAssay | GR-GFP Redistribution | | AID | 450 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 29 | [SID11112959] | Inactive | | | GR-GFP Redistribution [AID450, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | BioAssay | GR-GFP Redistribution | | AID | 450 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 30 | [SID11112959] | Inactive | | | GR-GFP Redistribution [AID450, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | BioAssay | GR-GFP Redistribution | | AID | 450 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 31 | [SID11112959] | Inactive | | | GR-EFC Redistribution [AID451, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | BioAssay | GR-EFC Redistribution | | AID | 451 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 32 | [SID11112959] | Inactive | | | GR-EFC Redistribution [AID451, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | BioAssay | GR-EFC Redistribution | | AID | 451 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 33 | [SID11112959] | Inactive | | | GR-EFC Redistribution [AID451, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | BioAssay | GR-EFC Redistribution | | AID | 451 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 34 | [SID11112959] | Inactive | | | GR-EFC Redistribution [AID451, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | BioAssay | GR-EFC Redistribution | | AID | 451 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 35 | [SID26757851] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 36 | [SID26757851] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 37 | [SID26757851] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 38 | [SID26757851] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 39 | [SID26757851] | Inactive | Potency | | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 40 | [SID26757851] | Inactive | Potency | | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 41 | [SID26757851] | Inactive | Potency | | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 42 | [SID26757851] | Inactive | Potency | | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 43 | [SID56463089] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 44 | [SID56463089] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 45 | [SID11112959] | Inactive | Potency | | qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing [AID925, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 11112959 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing | | AID | 925 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 46 | [SID56463089] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 47 | [SID56463089] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 48 | [SID56463089] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 49 | [SID56463089] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56463089 | | CID | 19518 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 50 | [SID26757851] | Inactive | Potency | | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26757851 | | CID | 19518 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|